Skip to main content
SpringerLink
Log in

Cellular motility and prostatic carcinoma metastases

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Virchow R: Über bewegliche thierische Zellen. Archiv für Pathologische Anatomie und Physiologie und dur Klinische Medizin 28: 237–240, 1863

    Google Scholar 

  2. Gey GO: Some aspects of the constitution and behavior of normal and malignant cells maintained in continuous culture. The Harvey Lectures, Series L: 154-229, 1954-1955

  3. Wood S Jr, Baker RR, Marzocchi R:In vivo studies of tumor behavior: Locomotion of and interrelationships between normal cells and cancer cells. In: Frei E (ed) The Proliferation and Spread of Neoplastic Cells. Williams and Wilkins Co., Baltimore, Ill., 1968, pp 496–510

    Google Scholar 

  4. Hosaka S, Suzuki M, Goto M, Sato H: Motility of rat ascites hepatoma cells, with reference to malignant characteristics in cancer metastasis. Gann 69: 273–276, 1978

    Google Scholar 

  5. Haemmerli G, Strauli P:In vitro motility of cells from human epidermoid carcinoma. A study by phase-contrast and reflection-contrast cinematography. Int J Cancer 27: 603–610, 1981

    Google Scholar 

  6. Manger RL, Heckman CA: Behavioral anomalies of highly malignant respiratory tract epithelial cells. Cancer Res 44: 668–696, 1984

    Google Scholar 

  7. Verschueren H, Van Larebeke N: A new model for the quantitative analysis of cell movementin vivo. Definition of a shape change factor. Cytometry 5: 557–561, 1984

    Google Scholar 

  8. Fulton AB: The Cytoskeleton: Cellular Architecture and Choreography. Chapman and Hall, New York, 1984, pp 55–58

    Google Scholar 

  9. Liotta LA, Mandler R, Murano G, Katz DA, Gordon RK, Chiang PK, Schiffmann E: Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 83: 3302–3306, 1986

    Google Scholar 

  10. Stracke ML, Guirguis R, Liotta LA, Schiffman E: Pertussis toxin inhibits stimulated motility independently of the adenylate cyclase pathway in human melanoma cells. Biochem Biophys Res Commun 146: 339–345, 1987

    Google Scholar 

  11. Watanabe H, Nabi IR, Raz A: The relationship between motility factor receptor internalization and the lung colonization capacity of murine melanoma cells. Cancer Res 51: 2699–2705, 1991

    Google Scholar 

  12. Sato Y, Rifkin DB: Autocrine activity of basic fibroblast growth factor: Regulation of endothelial cell movement plasminogen activator synthesis. J Cell Biol 107: 1199–1205, 1988

    Google Scholar 

  13. Stracke ML, Kohn EC, Aznavoorian SA, Wilson LL, Salomon D, Krutzsch HC, Liotta LA, Schiffman E: Insulin-like growth factors stimulate chemotaxis in human melanoma cells. Biochem Biophys Res Commun 153: 1076–1083, 1988

    Google Scholar 

  14. Sobue K, Fujio Y, Kanda K: Tumor promoter induces reorganization of actin filaments and calspectin (fodrin or nonerythroid spectrin) in 3T3 cells. Proc Natl Acad Sci USA 85: 482–486, 1988

    Google Scholar 

  15. Stoker M, Gherardi E, Perryman M, Gray J: Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327: 239–242, 1987

    Google Scholar 

  16. Treiger B, Isaacs J: Expression of a transfected v-Harvey-ras oncogene in a Dunning rat prostate adenocarcinoma and the development of high metastatic ability. J Urol 140: 1580–1588, 1988

    Google Scholar 

  17. Partin AW, Isaacs JT, Treiger B, Coffey DS: Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with the v-Harvey-ras oncogene. Cancer Res 48: 6050–6053, 1988

    Google Scholar 

  18. Bernstein SC, Weinberg RA: Expression of the metastatic phenotype in cells transfected with human metastatic tumor DNA. Proc Natl Acad Sci USA 82: 1726–1730, 1985

    Google Scholar 

  19. Tarin D, Cairney M, Taylor A: Transfer of metastatic capability with genomic DNA. Proc Am Assoc Cancer Res 32: 64 (abstract), 1991

    Google Scholar 

  20. Mohler JL, Partin AW, Coffey DS: Cancer cell motility: A visual grading system for assessment of prognosis in prostatic carcinoma. In: Gardner W, Coffey DS (eds) Prognostic Cytometry and Cytopathology of Prostate Cancer. Elsevier, New York, NY, 1989, pp 337–348

    Google Scholar 

  21. Mohler JL, Partin AW, Marshall FF, Coffey DS: The motility of cells from renal cell carcinoma (videotape). J Urol 139: 32, 1988

    Google Scholar 

  22. Guirguis R, Schiffmann E, Liu B, Birkbeck D, Engel J, Liotta L: Detection of autocrine motility factor in urine as a marker of bladder cancer. JNCI 80: 1203–1211, 1988

    Google Scholar 

  23. Dunning WF: Prostatic cancer in the rat. Natl Cancer Inst Monogr 12: 351–369, 1963

    Google Scholar 

  24. Isaacs JT, Isaacs WB, Fitz WFJ, Scheres J: Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate 9: 261–281, 1986

    Google Scholar 

  25. Minagawa H, Miyauchi T, Wakisaka M, Fuse H, Matsuzaki O, Shimazaki J: Properties of two sublines derived from rat prostatic adenocarcinoma (Dunning R-3227 tumor). Gann 74: 524–533, 1983

    Google Scholar 

  26. Mohler JL, Partin AW, Isaacs JT, Coffey DS: Metastatic potential by a visual grading system of cell motility: Prospective validation in the Dunning R-3327 prostatic adenocarcinoma model. Cancer Res 48: 4312, 1988

    Google Scholar 

  27. Mohler JL, Partin AW, Isaacs WB, Coffey DS: Time lapse videomicroscopic identification of Dunning R-3227 adenocarcinoma and normal rat prostate cells. J Urol 137: 544–547, 1987

    Google Scholar 

  28. Mohler JL, Partin AW, Coffey DS: Prediction of metastatic potential by a new grading system of cell motility: Validation in the Dunning R-3327 prostatic adenocarcinoma model. J Urol 138: 168–170, 1987

    Google Scholar 

  29. Doyle GM, Sharief Y, Mohler JL: Prediction of metastatic potential by cancer cell motility in the Dunning R-3327 prostatic adenocarcinomain vivo model. J Urol 147: 514–518, 1992

    Google Scholar 

  30. Doyle GM, Mohler JL: Prediction of metastatic potential of aspirated prostatic cancer cells. J Urol 147: 756–759, 1992

    Google Scholar 

  31. Partin AW, Schoeniger JS, Mohler JL, Coffey DS: Fourier analysis of cell motility: Correlation of motility with metastatic potential. Proc Natl Acad Sci USA 86: 1254, 1989

    Google Scholar 

  32. Mohler JL, Levy F, Sharief Y: Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R-3327 rat prostatic adenocarcinoma model. Cancer Res 51: 6580–6585, 1991

    Google Scholar 

  33. Heimark RL, Twardzik DR, Schwartz SM: Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 233: 1078–1080, 1986

    Google Scholar 

  34. Leschey KH, Hines J, Singer JH, Hackett SF, Campochiaro PA: Inhibition of growth factor effects in retinal pigment epithelial cells. Invest Ophthamol Vis Sci 32: 1770–1778, 1991

    Google Scholar 

  35. Hendrix MJC, Wood WR, Seftor EA, Lotan D, Nakajima M, Misiorowski RL, Seftor REB, Stetler-Stevenson WG, Bevacqua SJ, Liotta LA, Sobel ME, Raz A, Lotan R: Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Cancer Res 50: 4121–4130, 1991

    Google Scholar 

  36. Heppner GH: Perspectives in cancer research: Tumor heterogeneity. Cancer Res 44: 2259–2265, 1984

    Google Scholar 

  37. Noble RL: Hormonal control of growth and progression in tumors of Nb rats and a theory of action. Cancer Res 37: 82–94, 1977

    Google Scholar 

  38. DeWys WD: Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumor-related systemic growth-retarding factors. Cancer Res 32: 374–379, 1972

    Google Scholar 

  39. Poste G, Doll J, Fidler IJ: Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal population of B16 melanoma cells. Proc Natl Acad Sci USA 78: 6226–6230, 1981

    Google Scholar 

  40. Anonymous: Adjuvant tamoxifen in the management of operable breast cancer: The Scottish trial. Lancet 2: 171-175, 1987

  41. Isaacs JT, Coffey DS: Adaptationversus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma. Cancer Res 41: 5070–5075, 1981

    Google Scholar 

  42. Kozlowski JM, Ellis WJ, Grayhack JT: Advanced prostatic carcinoma. Early versus late endocrine therapy. Urol Clin N Amer 18: 15–24, 1991

    Google Scholar 

  43. Byar DP: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate. Cancer 32: 1126–1130, 1973

    Google Scholar 

  44. DeVita VT Jr: The relationship between tumor mass and resistance to chemotherapy. Cancer 51: 1209–1220, 1983

    Google Scholar 

  45. Goldie JH, Coldman AJ: A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63: 1727–1733, 1979

    Google Scholar 

  46. Robertson CN, Linehan WM, Pass HI, Gomella LG, Haas GP, Berman A, Merino M, Rosenberg SA: Preparative cytoreductive surgery in patients with metastatic renal cell carcinoma treated with adoptive immunotherapy with interleukin-2 or interleukin-2 plus lymphokine activated killer cells. J Urol 144: 614–618, 1990

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Division of Urology, CB # 7235, University of North Carolina at Chapel Hill, Chapel Hill, 27599-7235, North Carolina, NC, USA

    James L. Mohler

Authors
  1. James L. Mohler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mohler, J.L. Cellular motility and prostatic carcinoma metastases. Cancer Metast Rev 12, 53–67 (1993). https://doi.org/10.1007/BF00689790

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00689790

Key words

Search

Navigation